This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Tree.com (TREE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Tree.com (TREE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tree.com (TREE) Beats Q1 Earnings Estimates
by Zacks Equity Research
Tree.com (TREE) delivered earnings and revenue surprises of 33.78% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
TFS Financial (TFSL) Matches Q2 Earnings Estimates
by Zacks Equity Research
TFS Financial (TFSL) delivered earnings and revenue surprises of 0% and 4.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
LendingTree & NerdWallet: Which Digital Finance Stock is a Smart Bet?
by Riya Anand
TREE and NRDS are expanding their market share in the digital marketplace. Read on to know which is a smart bet for now.
Is Lending Tree Stock Worth Investing Ahead of Its Q1 Earnings?
by Riya Anand
TREE is set to report first-quarter 2025 results next week. Read on to know whether you should buy the stock now or wait.
LendingTree Rises 9.9% in a Year: Is the Stock Worth Buying Now?
by Riya Anand
TREE's revenue diversification efforts and expense management initiatives look encouraging. Read on to see whether the stock deserves a spot in your portfolio.
Why Is Tree.com (TREE) Down 3.4% Since Last Earnings Report?
by Zacks Equity Research
Tree.com (TREE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
by Zacks Equity Research
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.
5 Relative Price Strength Stocks to Navigate Today's Market
by Nilanjan Choudhury
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Tree.com (TREE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Tree.com (TREE) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.